QuidelOrtho Valuation
Is QDEL1 * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of QDEL1 * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: QDEL1 * (MX$1154) is trading below our estimate of fair value (MX$2249.31)
Significantly Below Fair Value: QDEL1 * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for QDEL1 *?
Other financial metrics that can be useful for relative valuation.
What is QDEL1 *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$3.04b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.8x |
Enterprise Value/EBITDA | 7.5x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does QDEL1 *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 5.9x | ||
688301 iRay Technology | 10.2x | 24.1% | CN¥19.1b |
IRTC iRhythm Technologies | 7.1x | 14.1% | US$3.5b |
MOVE Medacta Group | 4.4x | 11.4% | CHF2.2b |
6951 JEOL | 2x | 8.6% | JP¥326.2b |
QDEL1 * QuidelOrtho | 1x | 0.9% | Mex$3.0b |
Price-To-Sales vs Peers: QDEL1 * is good value based on its Price-To-Sales Ratio (1x) compared to the peer average (8.6x).
Price to Earnings Ratio vs Industry
How does QDEL1 *'s PE Ratio compare vs other companies in the Global Medical Equipment Industry?
Price-To-Sales vs Industry: QDEL1 * is good value based on its Price-To-Sales Ratio (1x) compared to the Global Medical Equipment industry average (3.6x).
Price to Sales Ratio vs Fair Ratio
What is QDEL1 *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate QDEL1 *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.